Table 4– Priorities for future research
Better genetic and biomarkers of response to (controller and symptomatic) treatment
More RCTs of (controller) treatment using clearly characterised groups of patients, including but not limited to:
 Symptom pattern and severity
 Atopic sensitisation and presence of allergic disease
 Family history of atopy, asthma and wheezing
Environmental exposures such as indoor allergens, tobacco smoke exposure and traffic air pollution; planned subgroup analyses of treatment response in RCTs based on the same variables or on prediction indices
Development and validation of better ways to assess symptoms, impact on the child’s daily activities and the parental perception of these symptoms
  • RCT: randomised controlled trial.